Adaptive response in hepatitis B virus infection

Journal of Viral Hepatitis

Volumn 21, Issue 5, 2014, Pages 305-313

  Loggi, E ^a,b   Gamal, N ^b   Bihl, F ^c   Bernardi, M ^b   Andreone, P ^b  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Ospedale Regionale di Bellinzona e Valli   (Switzerland)

Author keywords

B lymphocytes; CD4 lymphocytes; CD8 lymphocytes; Hepatitis B; immune response

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; NEUTRALIZING ANTIBODY;

ACUTE LIVER FAILURE; ADAPTIVE IMMUNITY; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HELPER CELL; HEPATITIS B; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INFECTION CONTROL; LONG TERM MEMORY; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STELLATE CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; VIRAL CLEARANCE; VIRUS IMMUNITY; HUMAN; IMMUNOLOGY; PATHOLOGY;

ADAPTIVE IMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS B; HUMANS;

EID: 84898472262     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12255     Document Type: Review

References (96)

1. Yan H, Zhong G, Xu G, et al,. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B an, nd D virus. Elife 2012; 1: e00049.
2. McMahon BJ,. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25: 3-8.
3. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-185.
4. Guidotti LG, Chisari FV,. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 2006; 1: 23-61.
5. Bertoletti A, Gehring AJ,. The immune response during hepatitis B virus infection. J Gen Virol 2006; 87: 1439-1449.
6. Bertoletti A, Ferrari C,. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2012; 61: 1754-1764.
7. McMahon BJ,. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int 2009; 3: 334-3428.
8. Alberti A, Diana S, Sculard GH, Eddleston AL, Williams R,. Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J 1978; 2: 1056-1058.
9. Hangartner L, Zinkernagel RM, Hengartner H,. Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 2006; 6: 231-243.
10. Seeger C, Mason WS,. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68.
11. Lada O, Benhamou Y, Poynard T, Thibault V,. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol 2006; 80: 2968-2975.
12. Matsue K, Kimura S, Takanashi Y, et al,. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma. Cancer 2010; 116: 4769-4776.
13. Mitchison NA,. T-cell-B-cell cooperation. Nat Rev Immunol 2004; 4: 308-312.
14. Milich DR, Chen M, Schodel F, Peterson DL, Jones JE, Hughes JL,. Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A 1997; 94: 14648-14653.
15. Lee BO, Tucker A, Frelin L, et al,. Interaction of the hepatitis B core antigen and the innate immune system. J Immunol 2009; 182: 6670-6681.
16. Ferrari C, Bertoletti A, Penna A, et al,. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 1991; 88: 214-222.
17. Loggi E, Bihl FK, Cursaro C, et al,. Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. PLoS ONE 2013; 8: e65327.
18. Raimondi G, Zanoni I, Citterio S, Ricciardi-Castagnoli P, Granucci F,. Induction of peripheral T cell tolerance by antigen-presenting B cells. II. Chronic antigen presentation overrules antigen-presenting B cell activation. J Immunol 2006; 176: 4021-4028.
19. Frommer F, Heinen TJ, Wunderlich FT, et al,. Tolerance without clonal expansion: self-antigen-expressing B cells program self-reactive T cells for future deletion. J Immunol 2008; 181: 5748-5759.
20. Moir S, Ho J, Malaspina A, et al,. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008; 205: 1797-1805.
21. Weiss GE, Crompton PD, Li S, et al,. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 2009; 183: 2176-2182.
22. Oliviero B, Cerino A, Varchetta S, et al,. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections. J Hepatol 2011; 55: 53-60.
23. Das A, Ellis G, Pallant C, et al,. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012; 189: 3925-3935.
24. Farci P, Diaz G, Chen Z, et al,. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci U S A 2010; 107: 8766-8771.
25. Rehermann B,. Immune responses in hepatitis B virus infection. Semin Liver Dis 2003; 23: 21-38.
26. Chisari FV, Isogawa M, Wieland SF,. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 2010; 58: 258-266.
27. Loggi E, Bihl F, Chisholm JV, et al,. Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft. J Hepatol 2009; 50: 625-630.
28. Loggi E, Micco L, Ercolani G, et al,. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. J Hepatol 2012; 56: 579-585.
29. Webster GJ, Reignat S, Brown D, et al,. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2004; 78: 5707-5719.
30. Boni C, Fisicaro P, Valdatta C, et al,. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007; 81: 4215-4225.
31. Sant AJ, McMichael A,. Revealing the role of CD4(+) T cells in viral immunity. J Exp Med 2012; 209: 1391-1395.
32. Thimme R, Wieland S, Steiger C, et al,. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77: 68-76.
33. Urbani S, Boni C, Amadei B, et al,. The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection. J Immunol 2005; 175: 7519-7529.
34. Ferrari C, Penna A, Bertoletti A, et al,. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145: 3442-3449.
35. Jung MC, Spengler U, Schraut W, et al,. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol 1991; 13: 310-317.
36. Penna A, Del Prete G, Cavalli A, et al,. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997; 25: 1022-1027.
37. Bocher WO, Herzog-Hauff S, Schlaak J,. Meyer zum Buschenfeld KH, Lohr HF. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Hepatology 1999; 29: 238-244.
38. Penna A, Artini M, Cavalli A, et al,. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996; 98: 1185-1194.
39. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV,. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104-1108.
40. Zerbini A, Pilli M, Boni C, et al,. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 2008; 134: 1470-1481.
41. Fisicaro P, Valdatta C, Boni C, et al,. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 2009; 58: 974-982.
42. Zhu J, Yamane H, Paul WE,. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010; 28: 445-489.
43. Zielinski CE, Corti D, Mele F, Pinto D, Lanzavecchia A, Sallusto F,. Dissecting the human immunologic memory for pathogens. Immunol Rev 2011; 240: 40-51.
44. Sallusto F, Lanzavecchia A,. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol 2009; 39: 2076-2082.
45. Oo YH, Shetty S, Adams DH,. The role of chemokines in the recruitment of lymphocytes to the liver. Dig Dis 2010; 28: 31-44.
46. Wasmuth HE, Tacke F, Trautwein C,. Chemokines in liver inflammation and fibrosis. Semin Liver Dis 2010; 30: 215-225.
47. Zeremski M, Petrovic LM, Chiriboga L, et al,. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 2008; 48: 1440-1450.
48. Zeremski M, Dimova R, Brown Q, Jacobson IM, Markatou M, Talal AH,. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. J Infect Dis 2009; 200: 1774-1780.
49. Tan AT, Koh S, Goh W, et al,. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol 2010; 52: 330-339.
50. Heydtmann M, Adams DH,. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology 2009; 49: 676-688.
51. Sallusto F, Zielinski CE, Lanzavecchia A,. Human Th17 subsets. Eur J Immunol 2012; 42: 2215-2220.
52. O'Quinn DB, Palmer MT, Lee YK, Weaver CT,. Emergence of the Th17 pathway and its role in host defense. Adv Immunol 2008; 99: 115-1163.
53. Zhang JY, Zhang Z, Lin F, et al,. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81-91.
54. Zhang GL, Xie DY, Ye YN, et al,. High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV. Liver Int 2014; 34: 266-273.
55. Li J, Qiu SJ, She WM, et al,. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS ONE 2012; 7: e39307.
56. Wang LY, Meng QH, Zou ZQ, et al,. Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci 2012; 57: 667-674.
57. Wang Q, Zhou J, Zhang B, et al,. Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis. PLoS Pathog 2013; 9: e1003410.
58. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F,. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10: 857-863.
59. Cobleigh MA, Robek MD,. Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Am J Pathol 2013; 182: 21-28.
60. Wang B, Zhao XP, Fan YC, Zhang JJ, Zhao J, Wang K,. IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line. Antiviral Res 2013; 97: 285-292.
61. Zhang Y, Cobleigh MA, Lian JQ, et al,. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 2011; 141: 1897-1906.
62. Josefowicz SZ, Lu LF, Rudensky AY,. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012; 30: 531-564.
63. Crispe IN,. Liver antigen-presenting cells. J Hepatol 2011; 54: 357-365.
64. Stoop JN, van der Molen RG, Baan CC, et al,. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41: 771-778.
65. Franzese O, Kennedy PT, Gehring AJ, et al,. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005; 79: 3322-3328.
66. Xu D, Fu J, Jin L, et al,. Circulating and liver resident CD4+ CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739-747.
67. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z,. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008; 123: 57-65.
68. Stross L, Gunther J, Gasteiger G, et al,. Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology 2012; 56: 873-883.
69. Vinuesa CG, Linterman MA, Goodnow CC, Randall KL,. T cells and follicular dendritic cells in germinal center B-cell formation and selection. Immunol Rev 2010; 237: 72-89.
70. Crotty S,. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011; 29: 621-663.
71. Baumjohann D, Preite S, Reboldi A, et al,. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 2013; 38: 596-605.
72. Fahey LM, Wilson EB, Elsaesser H, Fistonich CD, McGavern DB, Brooks DG,. Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J Exp Med 2011; 208: 987-999.
73. Yi JS, Du M, Zajac AJ,. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009; 324: 1572-1576.
74. Feng J, Lu L, Hua C, et al,. High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B. PLoS ONE 2011; 6: e21698.
75. Li Y, Ma S, Tang L, et al,. Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection. Hepatology 2013; 58: 1277-1286.
76. Morita R, Schmitt N, Bentebibel SE, et al,. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011; 34: 108-121.
77. Maini MK, Gudgeon N, Wedderburn LR, Rickinson AB, Beverley PC,. Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype. J Immunol 2000; 165: 5729-5737.
78. Bihl F, Loggi E, Chisholm JV, et al,. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection. Liver Transpl 2008; 14: 478-485.
79. Webster GJ, Reignat S, Maini MK, et al,. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000; 32: 1117-1124.
80. Tan AT, Loggi E, Boni C, et al,. Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol 2008; 82: 10986-10997.
81. Reignat S, Webster GJ, Brown D, et al,. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 2002; 195: 1089-1101.
82. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV,. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36.
83. Guidotti LG, Ando K, Hobbs MV, et al,. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A 1994; 91: 3764-3768.
84. Wherry EJ,. T cell exhaustion. Nat Immunol 2011; 12: 492-499.
85. Wherry EJ, Ha SJ, Kaech SM, et al,. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007; 27: 670-684.
86. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P,. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004; 114: 701-712.
87. Gehring AJ, Sun D, Kennedy PT, et al,. The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J Virol 2007; 81: 2940-2949.
88. Boettler T, Panther E, Bengsch B, et al,. Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol 2006; 80 (7): 3532-3540.
89. Fisicaro P, Valdatta C, Massari M, et al,. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010; 138: 682-693, 693 e1-4.
90. Fisicaro P, Valdatta C, Massari M, et al,. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV. Gastroenterology 2012; 143 (1576-1585): e4.
91. Walunas TL, Bakker CY, Bluestone JA,. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541-2550.
92. Schurich A, Khanna P, Lopes AR, et al,. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 2011; 53: 1494-1503.
93. Das A, Hoare M, Davies N, et al,. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008; 205: 2111-2124.
94. Lopes AR, Kellam P, Das A, et al,. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 2008; 118: 1835-1845.
95. Maini MK, Schurich A,. The molecular basis of the failed immune response in chronic HBV: therapeutic implications. J Hepatol 2010; 52: 616-619.
96. Michel ML, Deng Q, Mancini-Bourgine M,. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. J Hepatol 2011; 54: 1286-1296.